Form 4 · Filed Jul 25, 2026, 01:00 AM UTC
ATRA/Atara Biotherapeutics, Inc.
Redmile Group, LLC — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | M | other | 195,211 | — | — | 636,912 |
| Jul 22, 2026 | F | other | 60 | — | — | 636,852 |
| Jul 22, 2026 | M | other | 101,089 | — | — | 0 |
| Jul 22, 2026 | M | other | 38,735 | — | — | 0 |
| Jul 22, 2026 | M | other | 55,387 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-086733